$8.90
+0.0500 (+0.565%)
At Close: Jul 31, 2026
Burning Rock Biotech (BNR) Q3 2022 Earnings Call Transcript
11:41am, Wednesday, 16'th Nov 2022
Burning Rock Biotech Limited (NASDAQ:BNR ) Q3 2022 Earnings Conference Call November 16, 2022 8:30 AM ET Company Participants Yusheng Han - Chairman and CEO Dr. Shaokun Chuai - COO Leo Li - CFO Confer
Burning Rock Provides Third Quarter 2022 Business Updates and Schedules Earnings Release on November 16, 2022
12:46am, Tuesday, 25'th Oct 2022
GUANGZHOU, China, Oct. 25, 2022 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequenc
Best Penny Stocks To Buy? 4 That Redditors Are Watching Now
03:30pm, Wednesday, 31'st Aug 2022
Penny stocks to buy according to Reddit sentiment. The post Best Penny Stocks To Buy?
Why Shares of Alibaba, JD.com, and Burning Rock Biotech Are Rising Today
01:24pm, Wednesday, 31'st Aug 2022
Chinese stocks continue to benefit from a preliminary agreement between the U.S. and China on a long-standing auditing dispute.
Burning Rock Biotech (BNR) Q2 2022 Earnings Call Transcript
11:56am, Wednesday, 31'st Aug 2022
Burning Rock Biotech Limited (NASDAQ:BNR ) Q2 2022 Earnings Conference Call August 31, 2022 8:30 AM ET Company Participants Yusheng Han - Chief Executive Officer Shannon Chuai - Chief Operating Office
Burning Rock Biotech Limited Sponsored ADR (BNR) Reports Q2 Loss, Tops Revenue Estimates
08:17am, Wednesday, 31'st Aug 2022
Burning Rock Biotech Limited Sponsored ADR (BNR) delivered earnings and revenue surprises of -2.78% and 0.69%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahe
Burning Rock Provides Second Quarter 2022 Business Updates and Schedules Earnings Release on August 31, 2022
09:10am, Thursday, 04'th Aug 2022
GUANGZHOU, China, Aug. 04, 2022 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequenc
Cathie Wood Is Selling Gene Editing Stocks. Here's Why.
11:45am, Thursday, 02'nd Jun 2022
Cathie Wood has recently sold off large positions in several gene-editing stocks from her ARKG ETF. What's behind Wood's latest moves?
Burning Rock Biotech Limited (BNR) CEO Yusheng Han on Q1 2022 Results - Earnings Call Transcript
12:42pm, Tuesday, 31'st May 2022
Burning Rock Biotech Limited (NASDAQ:BNR ) Q1 2022 Earnings Conference Call May 31, 2022 8:30 AM ET Company Participants Yusheng Han - Founder, Chairman & CEO Leo Li - CFO Shannon Chuai - COO Conferen
Burning Rock Schedules First Quarter of 2022 Earnings Release on May 31, 2022
04:00am, Monday, 16'th May 2022
GUANGZHOU, China, May 16, 2022 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequenci
Tesla Bull Cathie Wood Bought $1M Shares In This Biotech Stock Today
10:09pm, Thursday, 24'th Mar 2022
Tesla Inc (NASDAQ: TSLA) bull Cathie Wood led Ark Investment Management on Thursday further raised its exposure in China-based biotech company Burning Rock Biotech Ltd (NASDAQ: BNR). The investment fi
Burning Rock Biotech Limited (BNR) CEO Yusheng Han on Q4 2021 Results - Earnings Call Transcript
01:38pm, Tuesday, 22'nd Mar 2022
Burning Rock Biotech Limited (BNR) CEO Yusheng Han on Q4 2021 Results - Earnings Call Transcript
Burning Rock Schedules Fourth Quarter and Full Year 2021 Earnings Release on March 22, 2022
11:30pm, Monday, 21'st Feb 2022
GUANGZHOU, China, Feb. 22, 2022 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequenc
Burning Rock Biotech Ltd - ADR Shares Approach 52-Week Low - Market Mover
09:15am, Tuesday, 11'th Jan 2022 Kwhen Finance
Burning Rock Biotech Ltd - ADR (BNR) shares closed today at 1.5% above its 52 week low of $8.90, giving the company a market cap of $801M. The stock is currently down 3.6% year-to-date, down 63.0% over the past 12 months, and down 62.7% over the past five years. This week, the Dow Jones Industrial Average fell 0.3%, and the S&P 500 fell 1.9%. Trading Activity Trading volume this week was 50.4% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.0. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought.
Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by -58.6% The company's stock price performance over the past 12 months lags the peer average by 315.3%
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.
Burning Rock Biotech Ltd - ADR Shares Fall 2.6% Below Previous 52-Week Low - Market Mover
01:20am, Thursday, 30'th Dec 2021 Kwhen Finance
Burning Rock Biotech Ltd - ADR (BNR) shares closed 2.6% lower than its previous 52 week low, giving the company a market cap of $864M. The stock is currently down 57.1% year-to-date, down 57.8% over the past 12 months, and down 59.8% over the past five years. This week, the Dow Jones Industrial Average rose 2.6%, and the S&P 500 rose 3.0%. Trading Activity Trading volume this week was 57.8% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.1. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed below its Bollinger band, indicating it may be oversold.
Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 680.1% The company's stock price performance over the past 12 months lags the peer average by 601.7%
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.
Sign In
Buy BNR